Transactions
Amador Bioscience acquired A2PG
Dec. 2021
Client: Amador Bioscience provides translational sciences and clinical pharmacology services to biopharmaceutical companies
Role: Edgemont Partners acted as exclusive financial advisor to Amador Bioscience on its acquisition of A2PG
Location: Pleasanton, CA
Sector: Pharmaceutical Services
Lead Banker: Andrew Karlin
acquired
